Loading ...

T Cell Assay Assessment

(

Diabetes Consortium

)

ITN Protocol #:

ITN508AI

Branded Name:

Diabetes Consortium

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Withdrawn

Summary:

Comparative Study Between the Elispot, Tetramer, CFSE and CK Elispot Assay

Clinical Operations Manager

Study Personnel:

Protocol Chair

Carol Soppecsoppe@immunetolerance.org

Work: 

415-353-4879